The bill amends the Public Health Code of Michigan by adding a new section, 17748g, which mandates specific labeling requirements for drugs packaged in blister packs. According to the new provision, any drug that is not classified as a controlled substance and is packaged or repackaged by a manufacturer in a blister pack for distribution within the state must have each blister cell, or the backing of the blister pack if it lacks perforated cells, clearly labeled with the generic name of the drug.

This legislative change aims to enhance transparency and ensure that consumers have access to essential information about the medications they are using. By requiring the generic name to be displayed prominently, the bill seeks to promote safer medication practices and facilitate better understanding among patients and healthcare providers.

Statutes affected:
House Introduced Bill: 333.1101, 333.25211